- Home
- ANTE vs APVO Comparison
ANTE vs APVO Comparison
Compare ANTE & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTE
- APVO
- Stock Information
- Founded
- ANTE 2005
- APVO 2016
- Country
- ANTE China
- APVO United States
- Employees
- ANTE N/A
- APVO N/A
- Industry
- ANTE Advertising
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- ANTE Consumer Discretionary
- APVO Health Care
- Exchange
- ANTE Nasdaq
- APVO Nasdaq
- Market Cap
- ANTE 6.7M
- APVO 6.5M
- IPO Year
- ANTE N/A
- APVO N/A
- Fundamental
- Price
- ANTE $0.45
- APVO $4.50
- Analyst Decision
- ANTE
- APVO Strong Buy
- Analyst Count
- ANTE 0
- APVO 1
- Target Price
- ANTE N/A
- APVO $296.00
- AVG Volume (30 Days)
- ANTE 50.9K
- APVO 80.8K
- Earning Date
- ANTE 09-30-2024
- APVO 03-04-2025
- Dividend Yield
- ANTE N/A
- APVO N/A
- EPS Growth
- ANTE N/A
- APVO N/A
- EPS
- ANTE 2.64
- APVO N/A
- Revenue
- ANTE $500,000.00
- APVO N/A
- Revenue This Year
- ANTE N/A
- APVO N/A
- Revenue Next Year
- ANTE N/A
- APVO N/A
- P/E Ratio
- ANTE $0.17
- APVO N/A
- Revenue Growth
- ANTE N/A
- APVO N/A
- 52 Week Low
- ANTE $0.26
- APVO $3.65
- 52 Week High
- ANTE $2.90
- APVO $399.60
- Technical
- Relative Strength Index (RSI)
- ANTE 49.49
- APVO 38.76
- Support Level
- ANTE $0.42
- APVO $4.32
- Resistance Level
- ANTE $0.47
- APVO $4.75
- Average True Range (ATR)
- ANTE 0.04
- APVO 0.43
- MACD
- ANTE 0.00
- APVO 0.15
- Stochastic Oscillator
- ANTE 41.25
- APVO 22.66
About ANTE AirNet Technology Inc.
AirNet Technology Inc provides in-flight solutions to connectivity, entertainment, and digital multimedia in China. It offers Internet connections through a network of satellites and land-based beacons, provides airline travelers with interactive entertainment, and breaking news, and furnishes corporate clients with advertisements tailored to the perceptions of the travelers. The revenues are mainly derived from selling advertising time slots on the companies advertising networks and cryptocurrency mining.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.